Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian M Dubuc

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|June 25, 2016
FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemiaAdrian M Dubuc, Matthew S Davids, Mirela Pulluqi, et al.
Brain Pathology (Zurich, Switzerland)|September 13, 2012
Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar developmentDonya Aref, Connor J Moffatt, Sameer Agnihotri, et al.
Current Protocols in Human Genetics|April 3, 2016
Reporting of Diagnostic Cytogenetic ResultsAnne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Molecular Cancer|March 26, 2014
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastomaPeter S Harris, Sujatha Venkataraman, Irina Alimova, et al.
Cancer Research|October 5, 2013
MyoD is a tumor suppressor gene in medulloblastomaJoyoti Dey, Adrian M Dubuc, Kyle D Pedro, et al.
World Neurosurgery|July 31, 2015
Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate DifferentiationYun Jee Kang, Wenya Linda Bi, Adrian M Dubuc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2018
Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Darrel Waggoner, Karen E Wain, Adrian M Dubuc, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypesAndres M Acosta, Lynette M Sholl, Brendan C Dickson, et al.
Cold Spring Harbor Molecular Case Studies|June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosisPanieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
Bioinformatics (Oxford, England)|November 28, 2020
Quantification of aneuploidy in targeted sequencing data using ASCETSLiam F Spurr, Mehdi Touat, Alison M Taylor, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|June 25, 2016
FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemiaAdrian M Dubuc, Matthew S Davids, Mirela Pulluqi, et al.
Brain Pathology (Zurich, Switzerland)|September 13, 2012
Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar developmentDonya Aref, Connor J Moffatt, Sameer Agnihotri, et al.
Current Protocols in Human Genetics|April 3, 2016
Reporting of Diagnostic Cytogenetic ResultsAnne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Molecular Cancer|March 26, 2014
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastomaPeter S Harris, Sujatha Venkataraman, Irina Alimova, et al.
Cancer Research|October 5, 2013
MyoD is a tumor suppressor gene in medulloblastomaJoyoti Dey, Adrian M Dubuc, Kyle D Pedro, et al.
World Neurosurgery|July 31, 2015
Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate DifferentiationYun Jee Kang, Wenya Linda Bi, Adrian M Dubuc, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2018
Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Darrel Waggoner, Karen E Wain, Adrian M Dubuc, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2021
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypesAndres M Acosta, Lynette M Sholl, Brendan C Dickson, et al.
Cold Spring Harbor Molecular Case Studies|June 2, 2021
Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosisPanieh Terraf, Lynette M Sholl, Matthew S Davids, et al.
Bioinformatics (Oxford, England)|November 28, 2020
Quantification of aneuploidy in targeted sequencing data using ASCETSLiam F Spurr, Mehdi Touat, Alison M Taylor, et al.
Pageof 6